238 related articles for article (PubMed ID: 24176521)
41. Reflectance confocal microscopy and features of melanocytic lesions: an internet-based study of the reproducibility of terminology.
Pellacani G; Vinceti M; Bassoli S; Braun R; Gonzalez S; Guitera P; Longo C; Marghoob AA; Menzies SW; Puig S; Scope A; Seidenari S; Malvehy J
Arch Dermatol; 2009 Oct; 145(10):1137-43. PubMed ID: 19841401
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Rodić N; Zampella J; Sharma R; Burns KH; Taube JM
J Cutan Pathol; 2015 Nov; 42(11):807-14. PubMed ID: 26239102
[TBL] [Abstract][Full Text] [Related]
43. The diagnostic yield in submitting nevi for histologic examination.
Reeck MC; Chuang TY; Eads TJ; Faust HB; Farmer ER; Hood AF
J Am Acad Dermatol; 1999 Apr; 40(4):567-71. PubMed ID: 10188675
[TBL] [Abstract][Full Text] [Related]
44. Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
Elder DE; Piepkorn MW; Barnhill RL; Longton GM; Nelson HD; Knezevich SR; Pepe MS; Carney PA; Titus LJ; Onega T; Tosteson ANA; Weinstock MA; Elmore JG
J Am Acad Dermatol; 2018 Jul; 79(1):52-59.e5. PubMed ID: 29524584
[TBL] [Abstract][Full Text] [Related]
45. ["Dying nevus" or regressing melanoma].
Zalaudek I; Donati P; Catricalà C; Argenziano G
Hautarzt; 2011 Apr; 62(4):293-6. PubMed ID: 21461798
[TBL] [Abstract][Full Text] [Related]
46. Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions.
Rudolph P; Schubert C; Schubert B; Parwaresch R
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):169-78. PubMed ID: 9270500
[TBL] [Abstract][Full Text] [Related]
47. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
48. Melanocytic lesions - Staying out of trouble.
Brenn T
Ann Diagn Pathol; 2018 Dec; 37():91-102. PubMed ID: 30312883
[TBL] [Abstract][Full Text] [Related]
49. Histologic mimics of malignant melanoma.
Bsirini C; Smoller BR
Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
[TBL] [Abstract][Full Text] [Related]
50. Melanocytic nevi clinically simulating melanoma.
Makino E; Uchida T; Matsushita Y; Inaoki M; Fujimoto W
J Dermatol; 2007 Jan; 34(1):52-5. PubMed ID: 17204102
[TBL] [Abstract][Full Text] [Related]
51. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
52. The histopathology of dysplastic nevi. Continued controversy.
Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
[TBL] [Abstract][Full Text] [Related]
53. Variability in the Histopathological Diagnosis of Non-Melanocytic Lesions Excised to Exclude Melanoma.
Katz I; Azzi T; Lilleyman A; O'Brien B; Schapiro B; Thompson C; Prow T
Dermatol Pract Concept; 2021 Oct; 11(4):e2021094. PubMed ID: 35024222
[TBL] [Abstract][Full Text] [Related]
54. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel.
Weinstock MA; Barnhill RL; Rhodes AR; Brodsky GL
Arch Dermatol; 1997 Aug; 133(8):953-8. PubMed ID: 9267239
[TBL] [Abstract][Full Text] [Related]
55. Giant congenital melanocytic nevus.
Viana AC; Gontijo B; Bittencourt FV
An Bras Dermatol; 2013; 88(6):863-78. PubMed ID: 24474093
[TBL] [Abstract][Full Text] [Related]
56. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel.
Cook MG; Clarke TJ; Humphreys S; Fletcher A; McLaren KM; Smith NP; Stevens A; Theaker JM; Melia J
Histopathology; 1996 Jun; 28(6):497-512. PubMed ID: 8803593
[TBL] [Abstract][Full Text] [Related]
57. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
58. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
59. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
60. WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi.
Rosner K; Mehregan DR; Moussai D; Abrams J; Tromp G; Mehregan DA
J Cutan Pathol; 2009 Oct; 36(10):1077-82. PubMed ID: 19615003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
